Immunization Clinical Trial
Official title:
Adolescent Immunization Recall Systems: A Randomized Controlled Trial
Verified date | April 2017 |
Source | Boston Children’s Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine whether contacting the parents of adolescents overdue for routine vaccines or contacting both the parents AND adolescents overdue to routine vaccines improves immunization rates as compared to usual care.
Status | Completed |
Enrollment | 420 |
Est. completion date | July 31, 2011 |
Est. primary completion date | July 31, 2011 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 13 Years to 17 Years |
Eligibility |
Inclusion Criteria: - at least 13 years of age and under 18 years of age - had a billing code for an annual physical exam in the past 3 years at the Adolescent/Young Adult Medical Practice at Children's Hospital Boston - immunization record shows one of the following: no tetanus containing vaccine in the previous 5 years; no MCV4 vaccine; and/or has received the 1st VZV vaccine but not the 2nd VZV vaccine and has no documented history of the chicken pox Exclusion Criteria: - immunization record shows no vaccines or only influenza vaccines - sibling enrolled in the study - in the custody of the Department of Youth Services - in the custody of the Department of Child and Family Services |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital Boston | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston Children’s Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | receipt of vaccine of interest at 28 days | Vaccination records are assessed 28 days after the intervention to see if Tdap, MCV4, or the 2nd VZV vaccine were administered. | 28 days | |
Secondary | receipt of vaccine of interest at 1 year | Immunization records are assessed 1 year after the intervention to assess for receipt of Tdap, MCV4, and/or the 2nd VZV vaccine. | 1 year | |
Secondary | receipt of other vaccines at 28 days | Immunization records are assessed 28 days after the intervention to assess for receipt of any vaccine other than Tdap, MCV4, and the 2nd VZV. | 28 days | |
Secondary | receipt of other vaccines at 1 year | Immunization records are assessed 1 year after the intervention to assess for receipt of any vaccine other than Tdap, MCV4, and the 2nd VZV. | 1 year | |
Secondary | receipt of prior vaccines at 28 days | We will assess the immunization record at 28 days to see if it has been updated with vaccines given prior to the enrollment date to see if we successfully obtained copies of immunization records at other healthcare sites. | 28 days | |
Secondary | receipt of prior vaccines at 1 year | We will assess the immunization record at 1 year to see if it has been updated with vaccines given prior to the enrollment date to see if we successfully obtained copies of immunization records at other healthcare sites. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02526394 -
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
|
Phase 4 | |
Completed |
NCT01707212 -
Prenatal Education About Infant Immunization Pain Management
|
Phase 3 | |
Completed |
NCT01463176 -
Music Therapy as Procedural Support for Young Children Undergoing Immunizations
|
N/A | |
Completed |
NCT01193335 -
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
|
Phase 4 | |
Completed |
NCT04222595 -
FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV
|
N/A | |
Completed |
NCT05794113 -
Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform
|
N/A | |
Recruiting |
NCT01713322 -
Testing Educational Materials in a Paediatric Setting
|
Phase 3 | |
Not yet recruiting |
NCT03705455 -
Immunization Schedule Alert Platform
|
N/A | |
Recruiting |
NCT01601197 -
A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization
|
Phase 3 | |
Completed |
NCT01296906 -
Population Versus Practice-based Interventions to Increase Immunizations
|
N/A | |
Completed |
NCT01399814 -
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
|
Phase 3 | |
Completed |
NCT02609035 -
Immunization Services Model for Adult Rate Improvement
|
N/A | |
Recruiting |
NCT02200276 -
Influenza Immunization in Adults Over Age 75
|
N/A | |
Completed |
NCT01677702 -
Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization
|
N/A | |
Recruiting |
NCT05213000 -
Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
|
N/A | |
Completed |
NCT03188692 -
Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
|
Phase 3 | |
Completed |
NCT02432430 -
Comparison of Immunization Quality Improvement Dissemination Study
|
N/A | |
Completed |
NCT01379846 -
Study of TAK-816 in Healthy Infants
|
Phase 3 | |
Active, not recruiting |
NCT03943875 -
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
|
Phase 4 | |
Completed |
NCT02819895 -
PRIMM Trial (Phone Reminder for IMMunization)
|
N/A |